Want to get up to speed with immune checkpoint blockade therapy for cancer ?
Register now for this online 13-hour CPD course ‘Understanding immune checkpoint blockade therapy: a pillar of modern cancer treatment’, from the University of Birmingham, UK, starting on Jan 24th, 2024.
Ben Willcox retweeted
Exciting day for us launching our new #DiversityandInclusion framework! I’m so proud of the team and our membership for all we’ve done to date, but there’s always more we can do. Have a read to see how we are going to take this forward with our members and wonderful community 👇
✨Today we launch our #DiversityAndInclusion framework which renews our commitment to #EDI
It outlines how we’re going to work with our members & #immunology community to ramp up our work
#EDI is vital to the future of #immunology!
Read more ➡️bit.ly/3GwFroZ 1/n
Ben Willcox retweeted
26 years ago, a gunman entered
Dunblane Primary School in Scotland,
killing 16 kids and a teacher. The UK
govt responded by enacting tight gun
control legislation. In the 9400+ days
since, there have been a total of O
school shootings in the UK. #Uvalde
Great to get McMurray et al out in Cell Reports, a page turner about transcriptional control of adaptive gd T cells. Thx to all co-authors and congrats to the talented @JackMcMurray. Strong similarities to ab T cells bring things back to ligand recognition as key gd USP.
Replying to @LabWillcox
Thanks to all who contributed to this study, @martindavey85 @DrAnoukvB @WillcoxCarrie @MariaSharif_ @helenmed @Jamie_Rossjohn and others, and congratulations to first author @JackMcMurray 🥳
Ben Willcox retweeted
An ‘immunoantibiotic’ drug launches a two-pronged attack on antibiotic-resistant microbes. Learn more this terrific N&V by @Youcef_Mehellou & @profbenw
go.nature.com/3bvqshm
Super-impressive study by Singh et al in Nature on an ‘immunoantibiotic’ approach to tackle drug resistant microbes, enlisting help from γδ T cells. Check out our News and Views, co-authored with @Youcef_Mehellou. go.nature.com/3bvqshm @NatureNV @ImmunologyUoB @IMIBirmingham
Massive congratulations to David Bending for scooping an MRC Career Development Fellowship ! Great to see a young scientist get career-changing support. So happy for him and @BendingLab.
This Post is from an account that no longer exists. Learn more
Signed, sealed, delivered, installed and operational ! Thanks to @menala76 and the GE team for setting up our new ÄKTA Pure. Here's to the next 17 years ! #AKTA #chromatography #proteinpurification
In case you've been wondering what γδ T cells have been getting up to over the last 500m years, check out our latest review.
This Post is from an account that no longer exists. Learn more
Ben Willcox retweeted
Check out our new paper in Immunity 👉🏻 “Butyrophilin-like 3 Directly Binds a Human Vγ4+ T Cell Receptor Using a Modality Distinct from Clonally-Restricted Antigen”
cell.com/immunity/fulltext/S…
•
#gdTcells @forum_gd @unibirm_MDS @CIIC_UoB @ImmunologyUoB @ImmunityCP #immunology #Tcells
Read our Nat Comm study suggesting some human gamma delta T cells are MUCH more adaptive than thought ! bit.ly/2lDzNab #immunology
Ben Willcox retweeted
Mike Stubbington (Sanger Centre), seminar: “Exploring T cell fate and clonality using single cell transcriptomes”. TODAY Mon 9th S104, 3pm
Ben Willcox retweeted
Welcome to Week 2 of our Cancer Immunotherapy MOOC at Future Learn.Q: Why is cancer such a challenge for the immune system? #FLCancerTherapy
Ben Willcox retweeted
Great to see over 300 folks have played our ImmuneSmart Cell Challenge !
ciic.org.uk/immunesmart-cell…
#FLCancerTherapy
Massive thanks to Heather Long for all her work on the #FLCancerTherapy #mooc, and UoB's awesome MOOC team for making it happen
Fantastic to get our Cancer Immunotherapy #mooc going. Inspiring to see so many folks from around the world engaging! #FLCancerTherapy
Ben Willcox retweeted
Still time to sign up if you want to learn why Cancer Immunotherapy is a step-change in cancer treatment.
futurelearn.com/courses/canc…
Ben Willcox retweeted
Welcome to everyone starting our Cancer Immunotherapy MOOC today at Future Learn (#FLCancerTherapy). We hope you enjoy the course !!












